A phase III trial of Micronised tissue allografts (AmnioFix) for the treatment of plantar fasciitis.
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2017
At a glance
- Drugs DHACM (Primary)
- Indications Plantar fasciitis
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2017 New trial record
- 02 Aug 2017 According to a MiMedx media release, the comapny anticipates enrolling the first Phase 3 patient within the next 30 to 60 days.
- 02 Aug 2017 According to a MiMedx media release, the FDA has now accepted a further reduction in the overall follow-up duration for the Phase 3 trial to 6 months, which underlines that the product is safe.